CERO THERAPEUTICS HOLDINGS, INC. Prepaid Expense and Other Assets, Noncurrent
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Prepaid Expense and Other Assets, Noncurrent of $21.18 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent · last filed 2022-11-10
- 2022-09-30: Prepaid Expense and Other Assets, Noncurrent $21.18K.
- 2021-12-31: Prepaid Expense and Other Assets, Noncurrent $217.52K.
| Period end | Prepaid Expense and Other Assets, Noncurrent |
|---|---|
| 2022-09-30 | $21.18K 10-Q · filed 2022-11-10 |
| 2021-12-31 | $217.52K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |